resensitization
Showing 1 - 11 of 11
Penicillin Allergy Testing and Resensitization Rate
Completed
- Penicillin Allergy
- Behavioral allergy testing protocol
-
Thionville, Moselle, FranceCHR Metz Thionville
Jul 30, 2019
Postpartum Hemorrhage Trial in Toronto (Oxytocin)
Recruiting
- Postpartum Hemorrhage
-
Toronto, Ontario, CanadaMount Sinai Hospital
Oct 24, 2022
Second Phase of Oral Challenge Test in Suspected Long-standing
Active, not recruiting
- Allergy Penicillin
-
Paris 14, FranceGroupe Hospitalier Paris Saint-Joseph
Mar 30, 2022
Malignant Solid Tumor, Metastatic Cancer, Advanced Cancer Trial in Sacramento, New Brunswick (RRx-001, Irinotecan)
Terminated
- Malignant Solid Tumor
- +2 more
-
Sacramento, California
- +1 more
May 12, 2022
Small Cell Carcinoma, NSCLC, Neuroendocrine Tumors Trial in United States (RRx-001, Cisplatin, Etoposide)
Active, not recruiting
- Small Cell Carcinoma
- +3 more
- RRx-001
- +11 more
-
Palo Alto, California
- +9 more
May 12, 2022
Recurrent, Platinum-resistant Ovarian Cancer Trial in Milan (Decitabine, Carboplatin, Pegylated Liposomal Doxorubicin)
Recruiting
- Recurrent, Platinum-resistant Ovarian Cancer
- Decitabine
- +4 more
-
Milan, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Sep 3, 2021
Age-Related Macular Degeneration, Geographic Atrophy, Reticular Pseudodrusen Trial in Milan (Subthreshold 577 nm yellow
Completed
- Age-Related Macular Degeneration
- +2 more
- Subthreshold 577 nm yellow wavelength laser photo-coagulator
-
Milan, MI, ItalyOspedale San Raffaele
Feb 2, 2020
Burns Trial in Maywood (Ketamine, Sodium chloride)
Unknown status
- Burns
- Ketamine
- Sodium chloride
-
Maywood, IllinoisLoyola University Medical Center
Mar 13, 2019
Cholangiocarcinoma Trial in Baltimore (RRx-001, Gemcitabine and cisplatin)
Terminated
- Cholangiocarcinoma
- RRx-001
- Gemcitabine and cisplatin
-
Baltimore, MarylandJohns Hopkins Sidney Kimmel Comprehensive Cancer Center
Nov 13, 2019
Ovarian Cancer Trial in Indianapolis (decitabine)
Completed
- Ovarian Cancer
-
Indianapolis, IndianaIndiana University Cancer Center
Sep 19, 2014